A review published in
Genes & Diseases highlights how RNA molecules could help breast cancer cells respond more effectively to
radiotherapy. Researchers at Mashhad University of Medical Sciences examine
microRNAs and their inhibitors as potential tools for overcoming radiation resistance by restoring the mechanisms that trigger programmed cell death.
Radiotherapy damages cancer cells, but some tumours survive by disrupting
apoptosis, the process through which damaged cells dismantle themselves. When this protective mechanism is weakened, cancer cells can continue growing despite treatment. The review explores whether adjusting microRNAs could make these cells more vulnerable to radiation.
MicroRNAs are short RNA molecules that regulate gene expression. Depending on their targets and biological context, they can promote or suppress tumour growth.
AntagomiRs, also known as anti-miRNAs, are designed to inhibit particular microRNAs, offering another way to influence pathways controlling cell survival and treatment response.
The article brings together studies of breast cancer cells and animal models, distinguishing molecules linked to increased
radiosensitivity from those associated with resistance. It also identifies microRNAs that promote apoptosis but have not yet been investigated alongside radiation, providing candidates for further research.
Among the examples discussed, increasing
miR-200c enhanced radiation sensitivity and apoptotic cell death in breast cancer cell lines. Another molecule,
miR-139-5p, affected DNA repair and defences against reactive oxygen species. Increasing its activity allowed radiation-induced damage to accumulate, helping trigger cancer cell death.
The review also highlights
miR-22 and
miR-205, which influence pathways involving survival signals and DNA repair. These findings illustrate how different microRNAs can converge on a common objective: weakening the mechanisms that allow tumour cells to withstand irradiation.
Conversely,
miR-21 is associated with treatment resistance in breast cancer models. Studies reviewed found that blocking it with
anti-miR-21 increased apoptosis and radiation sensitivity in cell lines. This supports investigating both replacement of protective microRNAs and inhibition of those that favour cancer cell survival.
The findings remain
experimental and do not establish improved outcomes for patients receiving radiotherapy. Effects can vary between breast cancer subtypes and models, and molecules that enhance apoptosis alone cannot automatically be assumed to improve radiation response.
Further research must identify the most promising targets, confirm their effects in relevant tumour models, and establish
safety and effectiveness before clinical application. Understanding interactions among RNA molecules and their gene targets will also be important.
# # # # # #
Genes & Diseases publishes rigorously peer-reviewed and high quality original articles and authoritative reviews that focus on the molecular bases of human diseases. Emphasis is placed on hypothesis-driven, mechanistic studies relevant to pathogenesis and/or experimental therapeutics of human diseases. The journal has worldwide authorship, and a broad scope in basic and translational biomedical research of molecular biology, molecular genetics, and cell biology, including but not limited to cell proliferation and apoptosis, signal transduction, stem cell biology, developmental biology, gene regulation and epigenetics, cancer biology, immunity and infection, neuroscience, disease-specific animal models, gene and cell-based therapies, and regenerative medicine.
Scopus CiteScore: 10.4 |Impact Factor:14.6
# # # # # #
More information: https://www.keaipublishing.com/en/journals/genes-and-diseases/
Editorial Board: https://www.keaipublishing.com/en/journals/genes-and-diseases/editorial-board/
All issues and articles in press are available
online in
ScienceDirect (
https://www.sciencedirect.com/journal/genes-and-diseases).
Submissions to
Genes & Diseases may be made using
Editorial Manager (
https://www.editorialmanager.com/gendis/default.aspx).
Print ISSN: 2352-4820
eISSN: 2352-3042
CN: 50-1221/R
Contact Us: editor@genesndiseases.cn
X (formerly twitter): @GenesNDiseases (
https://x.com/GenesNDiseases)
# # # # # #
Reference
Maryam Najafi-Amiri, Mina Pourhabib-Mamaghani, Seyed Hamid Aghaee-Bakhtiari, Mohammad-Taghi Bahreyni-Toossi, Hosein Azimian, A comprehensive review on apoptotic miRNAs and antagomiRs in breast cancer: Enhancing radio sensitization, Genes & Diseases, Volume 13, Issue 6, 2026, 102024,
https://doi.org/10.1016/j.gendis.2025.102024
Funding
Mashhad University of Medical Sciences (Iran)